Calciterolin 0.25 & Calciterol (0.25mg). Steris Healthcare Pvt. Ltd.

May 13, 2024

Calciterolin 0.25

Calciterol (0.25mg)

Calciterolin 0.25 is a medication commonly prescribed for the treatment of calcium deficiency and related conditions such as osteoporosis. It contains calcitriol, which is a synthetic form of vitamin D that helps regulate calcium and phosphate levels in the body. Calciterolin 0.25 is available in the form of oral capsules and is typically taken once daily.

Uses of Calciterolin 0.25

Calciterolin 0.25 is primarily used to treat calcium deficiency and associated conditions such as osteoporosis, rickets, and hypoparathyroidism. Calcium is essential for maintaining strong bones and teeth, as well as for proper muscle function, nerve signaling, and blood clotting. Calciterolin 0.25 helps increase calcium absorption in the intestines and promotes bone mineralization, reducing the risk of fractures and other complications associated with calcium deficiency.

Dosage and Administration

The recommended dosage of Calciterolin 0.25 may vary depending on the patient's age, weight, and individual response to treatment. In adults, the usual dose is 0.25 to 2 micrograms once daily, taken orally with or without food. The dose may be adjusted based on the patient's serum calcium levels and response to treatment. It is important to follow the dosage instructions provided by your healthcare provider and not to exceed the recommended dose.

Side Effects of Calciterolin 0.25

While Calciterolin 0.25 is generally well-tolerated, it may cause side effects in some individuals. Common side effects may include nausea, vomiting, loss of appetite, constipation, and headache. These side effects are usually mild and transient, but patients should report any persistent or bothersome symptoms to their healthcare provider. In rare cases, Calciterolin 0.25 may cause more serious side effects such as hypercalcemia (high levels of calcium in the blood), kidney stones, or allergic reactions. Patients should seek medical attention if they experience any concerning symptoms while taking Calciterolin 0.25.

Conclusion

Calciterolin 0.25 is an effective medication for the treatment of calcium deficiency and related conditions such as osteoporosis. By increasing calcium absorption and promoting bone mineralization, it helps maintain strong bones and reduce the risk of fractures. While generally safe, Calciterolin 0.25 may cause side effects in some individuals, and patients should be monitored closely for adverse reactions. With proper dosage and administration, Calciterolin 0.25 can help improve bone health and overall well-being.

Article 2: Exploring the Benefits of Calciterolin 0.25 in Bone Health

Introduction to Calciterolin 0.25

Calciterolin 0.25 is a medication used in the management of calcium deficiency and related conditions such as osteoporosis. It contains calcitriol, which is a biologically active form of vitamin D that plays a key role in calcium metabolism and bone health. Calciterolin 0.25 helps increase calcium absorption in the intestines and promotes bone mineralization, reducing the risk of fractures and other complications associated with calcium deficiency.

Benefits of Calciterolin 0.25

Calciterolin 0.25 offers several benefits for bone health. Firstly, it helps maintain adequate levels of calcium in the blood, which is essential for maintaining strong bones and teeth. By promoting calcium absorption in the intestines, Calciterolin 0.25 helps prevent bone loss and reduce the risk of osteoporosis, a condition characterized by weakened bones and increased susceptibility to fractures. Additionally, Calciterolin 0.25 has been shown to improve muscle function, nerve signaling, and overall bone density, further supporting its role in promoting bone health and reducing the risk of falls and fractures.

Clinical Efficacy of Calciterolin 0.25

Numerous clinical studies have demonstrated the efficacy of Calciterolin 0.25 in improving bone health and reducing the risk of fractures. These studies have shown that Calciterolin 0.25 helps increase bone mineral density, improve bone turnover markers, and reduce the incidence of fractures in patients with osteoporosis and related conditions. Additionally, Calciterolin 0.25 has been shown to improve muscle strength and balance, further reducing the risk of falls and fractures in older adults.

Conclusion

Calciterolin 0.25 is an effective medication for the management of calcium deficiency and related conditions such as osteoporosis. By increasing calcium absorption and promoting bone mineralization, it helps maintain strong bones and reduce the risk of fractures. Clinical studies have demonstrated the efficacy of Calciterolin 0.25 in improving bone health and reducing the risk of fractures in patients with osteoporosis and related conditions. With its proven benefits and favorable safety profile, Calciterolin 0.25 plays a key role in promoting bone health and overall well-being.Steris Healthcare Pvt Ltd, founded by a group of expert professionals in the pharmaceutical industry in February 2018, operates as Sterispharma. This company, which is based in Navi Mumbai, holds certifications from WHO, GMP, and ISO. Its commitment is to provide high-quality drugs at affordable prices to its customers throughout India, following the rigorous guidelines set by the WHO. Steris offers the convenience of an online pharmacy where customers can easily buy medicines and enjoy the benefit of home delivery. At Steris, the mission is to supply a wide array of healthcare products designed to meet the varied needs of the medical community. Whether it is advanced treatments, medications for rare conditions, or basic health necessities, Sterispharma strives to serve the healthcare industry’s broad demands. gynecology, Pediatrics, Dental care, and Dermatology. The extensive product lineup from Steris includes treatments for various health areas such as Cardiology, Asthma, Respiratory issues, Nasal conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental care, and Dermatology.

 For further information: 

  EMAIL:  info@sterispharma.com  / contact@sterispharma.com   

 CALL/WHATSAPP: 7877551268, 7849827488

 BUY NOW

 

 

 

 

SHARE WITH